Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning in primary refractory prolymphocytic leukemia: graft-versus-leukemia effect without graft-versus-host disease

Abstract

A patient with progressive prolymphocytic leukemia (PLL) received an allogeneic stem cell transplant using a reduced intensity conditioning regimen to avoid prohibitive toxicities. Early in the post-tranplant period, a high donor-derived CD8+ count was observed. One year from transplantation, the patient was in complete remission, fully donor chimeric and with a normal performance status, suggesting that this approach may represent a useful treatment option in patients with refractory PLL.

Bone Marrow Transplantation (2001) 28, 1155–1156.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Melo JV, Catovsky D, Galton DA . The relationship between chronic lymphocytic leukemia and prolymphocytic leukemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group Br J Haematol 1986 63: 377–387

    Article  CAS  Google Scholar 

  2. Saven A, Lee T, Schultz M et al. Major activity of cladribine in patients with de novo B cell prolymphocytic leukemia J Clin Oncol 1997 15: 37–43

    Article  CAS  Google Scholar 

  3. Dohner H, Ho AD, Thaler J et al. Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group J Natl Cancer Inst 1993 85: 658–662

    Article  CAS  Google Scholar 

  4. Michallet M, Archimbaud E, Bandini G et al. HLA-identical sibling bone marrow tranplantation in younger paients with lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry Ann Intern Med 1996 124: 311–315

    Article  CAS  Google Scholar 

  5. Mehta J, Powles R, Singhal S et al. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia Bone Marrow Transplant 1996 17: 371–375

    CAS  PubMed  Google Scholar 

  6. Rondòn G, Giralt S, Huh Y et al. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia Bone Marrow Transplant 1996 18: 669–672

    PubMed  Google Scholar 

  7. Barrett J, Childs R . Non-myeloablative stem cell transplants Br J Haematol 2000 111: 6–17

    Article  CAS  Google Scholar 

  8. Champlin R, Khouri I, Shimoni A et al. Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy Br J Haematol 2000 111: 18–29

    Article  CAS  Google Scholar 

  9. Khouri IF, Przepiorka D, van Besian K et al. Allogeneic blood or marrow transplantation for chronic lymphocytic leukemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease Br J Haematol 1997 97: 466–473

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Castagna, L., Nozza, A., Bertuzzi, A. et al. Allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning in primary refractory prolymphocytic leukemia: graft-versus-leukemia effect without graft-versus-host disease. Bone Marrow Transplant 28, 1155–1156 (2001). https://doi.org/10.1038/sj.bmt.1703309

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703309

Keywords

This article is cited by

Search

Quick links